Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication after endoscopic sinus surgery for prevention of nasal polyp recurrence
IRCT20120215009014N309Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of amoxicillin, metronidazole, bismuth subsalicylate and pantoprazole in nasal polyp (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Recurrence of sinonasal polyps. Started May 2018; status: completed.
02
Drugs
amoxicillinmetronidazolebismuth subsalicylatepantoprazole
03
Conditions
nasal polyp
Beyond the preview
Go deeper on IRCT20120215009014N309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N309.